Best practices for treating MASKNE in children and adolescents

Article

How to prevent, minimize, and treat maskne

Contemporary Pediatrics® recently spoke with Alanna F. Bree, MD, a board-certified pediatric dermatologist and clinical assistant professor of Dermatology at Baylor College of Medicine and Texas Children’s Hospital in Houston, Texas, as well as a Society of Pediatric Dermatology member, about maskne, including how long it has been around (since before the pandemic); how maskne presents differently in young children compared to teenagers; and how to best treat and prevent.

Newsletter

Access practical, evidence-based guidance to support better care for our youngest patients. Join our email list for the latest clinical updates.

Subscribe Now!
Recent Videos
John Browning, MD, provides practical skincare reminders ahead of summer season
How fragrance plays a role in atopic dermatitis treatments, with John Browning, MD
Jennifer Soung, MD reacts to FDA approval of roflumilast foam 0.3%
Russell Libby, MD, FAAP
Lawrence Eichenfield, MD
Wendy Ripple, MD
Wendy Ripple, MD
Lawrence Eichenfield, MD
Related Content
An 11-year-old boy with a petechial rash: A peculiar presentation

An 11-year-old boy with a petechial rash: A peculiar presentation

Drashti Patel, BS, BA;Jyoti Budania, MD
July 9th 2025
Article

His vital signs in clinic were within normal limits, and the only additional finding at this time was a nontender, nonpruritic, and nonpalpable petechial rash on the bilateral lower extremities.

stock image of a hemangioma

Recognize & Refer: Hemangiomas in pediatrics

Lisette Hilton
July 17th 2019
Podcast

Contemporary Pediatrics sits down exclusively with Sheila Fallon Friedlander, MD, a professor dermatology and pediatrics, to discuss the one key condition for which she believes community pediatricians should be especially aware-hemangiomas.

Mercedes Gonzalez, MD, discusses phase 2 trial of roflumilast cream 0.05% for infant atopic dermatitis

Mercedes Gonzalez, MD, discusses phase 2 trial of roflumilast cream 0.05% for infant atopic dermatitis

Mercedes E. Gonzalez, MD
June 27th 2025
Article

Roflumilast cream 0.05% is being studied for mild-to-moderate AD in infants aged 3 months to under 2 years in a new phase 2 trial.

Treating Patients with Trichotillomania and Other Related Behaviors

Treating Patients with Trichotillomania and Other Related Behaviors

Jon E. Grant, JD, MD, MPH
September 13th 2011
Podcast

Dr Jon E. Grant talks about the genetics, neurobiology, and cognitive processes of body-focused repetitive behaviors, which include trichotillomania, skin picking, and other behaviors.

FDA extends review of ruxolitinib cream for pediatric atopic dermatitis | Image credit: Contemporary Pediatrics.

FDA extends review of ruxolitinib cream for pediatric atopic dermatitis

Morgan Ebert, Managing Editor
June 20th 2025
Article

The FDA has extended the review of ruxolitinib for atopic dermatitis in children 2 to 11 years to September 2025 to evaluate new CMC data.

FDA approves new presentation of ustekinumab-stba biosimilar for plaque psoriasis, psoriatic arthritis | Image Credit: Contemporary Pediatrics

FDA approves new presentation of ustekinumab-stba biosimilar for plaque psoriasis, psoriatic arthritis

Joshua Fitch, Senior Editor
June 16th 2025
Article

The approval for ustekinumab-stba now offers all dosage forms to the reference product, ustekinumab, and is indicated for patients aged 6 to 17 years.

© 2025 MJH Life Sciences

All rights reserved.